Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Vanda Pharma soars
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
UK-based Cycle Pharmaceuticals on Monday reaffirmed its offer to buy Vanda Pharmaceuticals in a deal that values the US drugmaker at $488 million, despite a regulatory setback for its stomach condition drug in September.
Vanda Pharma soars as Cycle Pharma reiterates $8/share offer
Vanda Pharmaceuticals (NASDAQ:VNDA) jumped 17% in premarket trading after Cycle Pharmaceuticals reaffirmed its $8/share all cash offer for the company. "Cycle is making its renewed proposal public for the benefit of Vanda shareholders in light of the Vanda Board’s continued refusal to engage following the receipt of multiple premium proposals,
Cycle Pharma Is Said to Stand By $488 Million Offer for Vanda
Cycle Pharmaceuticals Ltd. is still interested in acquiring Vanda Pharmaceuticals Inc. after one of Vanda’s drugs failed to receive regulatory approval, according to people familiar with the matter.
Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
Proposal Delivers Immediate, Compelling and Certain Cash Value for Vanda Shareholders with a Highly Attractive Premium of 80% to Vanda's Closing Share Price on October 11, 2024. U
3h
AI Can Give Pharma More Shots On Goal, But Robust Data And Validation Are Key To Drug Approvals
The underlying issue for pharma companies using AI lies in the quality of the inputs and how AI models are used.
FiercePharma
2h
With election nearing, BMO analysts don't expect major pharma shake-ups from either candidate
In less than a month, Americans will head to the polls—or vote by mail—and elect the next president of the U.S. | While a ...
3h
Innate Pharma Names Jonathan Dickinson CEO, Executive Board Chairman
Herve Brailly, Innate's co-founder, has been serving as interim CEO and executive board chairman since the departure of Mondher Mahjoubi in January. Innate said Brailly will remain for the next few ...
5h
Mega pharma project one of many in play for North Carolina
Covance, based in New Jersey, opened its operation in RTP in 1997, growing from 180 employees to more than 500 at the time of ...
3d
on MSN
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
3h
5, including 3 directors of Gujarat pharma company, arrested in cocaine bust: Delhi Police
The Delhi Police Special Cell and the Gujarat Police recovered 518 kg of cocaine during a raid at a firm in Gujarat’s ...
Arabian Business
4h
Mubadala-owned KELIX Bio acquires four pharma assets of GHH
Mubadala Investment Company has empowered its new specialty pharmaceutical business, KELIX Bio, to acquire a 100 per cent ...
stockhead on MSN
12h
LTR Pharma’s ED treatment SPONTAN outperforms with 470% faster absorption
LTR Pharma’s pivotal trial for its novel intranasal formulation SPONTAN demonstrates it outperforms traditional oral erectile ...
5h
Sun Pharma Share Price Live: Sun Pharma Trading Update
Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.
1h
on MSN
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback